Autres langues Seres Therapeutics, Inc.

Actions

MCRB

US81750R1023

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 12/06/2024			Varia. 5j.	Varia. 1 janv.
0,7456 ^USD	-6,18 %		-30,32 %	-46,74 %

11/06	L'unité santé de Nestlé prend le contrôle total d'un traitement basé sur le microbiote	CI
07/06	SERES THERAPEUTICS, INC. : Canaccord Genuity réitère son opinion positive sur le titre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nestle's Health Unit to Take Full Control of Microbiota-Based Therapeutic	11/06
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	07/06
SERES THERAPEUTICS ENTERS INTO MEMORANDUM OF UNDERSTANDING FOR VOWST ASSET SALE TO NESTLE HEALTH SCIENCE	07/06
Seres Therapeutics - Nestle Health Science agrees to acquire global rights to VOWST, product it launched in June 2023	07/06
Nestlé Unit to Buy Vowst Assets from Seres Therapeutics	07/06
Sector Update: Health Care Stocks Advance Thursday Afternoon	06/06
Seres Therapeutics to Sell Vowst Assets to Nestle Health Science	06/06
Nestlé : rachat d'un médicament issu du microbiote	06/06
Nestlé Health holt sich Mittel zur Behandlung von Darmerkrankungen ins Haus	06/06
Nestle's health arm to buy first-ever fecal transplant pill	06/06
Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023	06/06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science	06/06
Seres Therapeutics: Q1 Earnings Snapshot	08/05
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates	08/05
Seres Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Seres Therapeutics : Accelaration/Increase of Financial Obligation - Form 8-K	07/05
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	06/05
Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024	06/05
Foreign automakers eager for Chinese partners at Beijing auto show	26/04
Battle for 'tech luxury' in China as EVs get smarter - and cheaper	25/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Seres Therapeutics, Inc.

Actions

MCRB

US81750R1023

Autres langues

Filtres